Analgesia Clinical Trial Services

We Know Pain

Our expertise navigating the unique challenges associated with pain management trials is not only helpful, it’s crucial. Because of our strong site relationships, reputation for meeting or even exceeding program timelines, expertise implementing decentralized clinical trial solutions, and insider’s understanding of the FDA’s Office of Neuroscience - Division of Anesthesiology, Addiction Medicine, and Pain Medicine (DAAP), Rho is the perfect pain partner to help your clinical development program reach its goals.

Overcoming the Challenges of Pain Trials

Pain management clinical trials come with inherent and unique challenges. Subjects drop out of trials for reasons including insufficient relief or pain management, treatment side effects, use of rescue medication, and the burden of multiple study assessments and visits. Recent studies in chronic and short-term pain report drop-out rates ranging from 5-40%. Missing data resulting from these subject drop-outs can make it difficult to interpret the trial results and can greatly impact the overall drug development process.

Partnering with Rho from Phase I through Marketing Applications provides program efficiencies and benefits, including faster site start-up, cost savings across projects, regulatory expertise and insights applied to clinical trial design and data collection. All of which can help shorten development timelines and increase your chances of success.